The Lancet Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet is an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people. The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health. The Lancet has grown from a 19th century pamphlet to a high impact, international journal. It has an SJR impact factor of 15.652.

The Lancet focuses its scope in these topics and keywords: health, disease, randomised, treatment, hiv, global, patients, authors, care, risk, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Non Open Access

Type of publications:

Publication frecuency: Weekly

Price

- €

Inmediate OA

- €

Embargoed OA

- €

Non OA

Metrics

The Lancet

15.652

SJR Impact factor

807

H Index

1377

Total Docs (Last Year)

4587

Total Docs (3 years)

22640

Total Refs

85917

Total Cites (3 years)

1226

Citable Docs (3 years)

22.23

Cites/Doc (2 years)

16.44

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


health, disease, randomised, treatment, hiv, global, patients, authors, care, risk, mortality, children, cancer, study, therapy, cardiovascular, systematic, controlled, human, prevention, kidney, Medicine



Best articles by citations

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT

J. Martin Bland DouglasG. Altman
31485 Citations View more

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang Yeming Wang Xingwang Li
24786 Citations View more

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou Ting Yu Ronghui Du
14666 Citations View more

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

13933 Citations View more

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen Min Zhou Xuan Dong
10980 Citations View more

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano Mohsen Naghavi Kyle Foreman
8435 Citations View more

ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS

Graham Teasdale Bryan Jennett
7849 Citations View more

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Stephen S Lim Theo Vos Abraham D Flaxman
7457 Citations View more

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013

Marie Ng Tom Fleming Margaret Robinson
6916 Citations View more

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Salim Yusuf Steven Hawken Stephanie Ôunpuu
6810 Citations View more

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

6277 Citations View more

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

6274 Citations View more
SHOW MORE ARTICLES

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Samantha K Brooks Rebecca K Webster Louise E Smith
6207 Citations View more

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Roujian Lu Xiang Zhao Juan Li
6055 Citations View more

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

5668 Citations View more

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Christopher J L Murray Theo Vos Rafael Lozano
5479 Citations View more

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm Douglas G Altman Matthias Egger
5433 Citations View more

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5421 Citations View more

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta Daniel F McAuley Michael Brown
5405 Citations View more

ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale

B JENNETT
5251 Citations View more

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Jasper Fuk-Woo Chan Shuofeng Yuan Kin-Hang Kok
5102 Citations View more

Inflammation and cancer: back to Virchow?

Fran Balkwill Alberto Mantovani
4854 Citations View more

The metabolic syndrome—a new worldwide definition

K George MM Alberti Paul Zimmet Jonathan Shaw
4813 Citations View more

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Theo Vos Abraham D Flaxman Mohsen Naghavi
4798 Citations View more

FAQS